# A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia

> **NCT06678165** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital of Guangxi Medical University** · enrollment: 3 (estimated)

## Conditions studied

- Transfusion Dependent Beta Thalassemia

## Interventions

- **DRUG:** YOLT-204

## Key facts

- **NCT ID:** NCT06678165
- **Lead sponsor:** First Affiliated Hospital of Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-31
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06678165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06678165, "A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06678165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*